CRH and colorectal carcinoma: The treatment of DLD1 and HCT116 cells with CRH increased STAT3 (Y705) phosphorylation, through the phosphorylation of JAK2, as well as the tube formation of human umbilical vein endothelial cells (HUVECs) in CRH-treated CRC medium.